New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China
Eisai plans to launch this medicine in China in the second quarter of fiscal year 2025.
May 28, 2025
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Eisai plans to launch this medicine in China in the second quarter of fiscal year 2025.